Mesoblast completes Phase 3 low back pain trial treatment as pivotal readout approaches
Mesoblast has completed treatment of 350 patients in its pivotal Phase 3 trial for chronic low back pain, with results expected in mid-2027.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Advancetc Limited
| Forum | Tag | Subject | View | Poster | |||||
|---|---|---|---|---|---|---|---|---|---|
| NSX - By Stock | A88 | Ann:AdvanceTC Limited 2017 Annual Financial Report (Price Sensitive) | Thread |
NSX News
|
0 | 147 | 0 | 31/03/18 | |
|
|||||||||
| NSX - By Stock | A88 | Ann:40530 NSX Preliminary/Final Statement (Price Sensitive) | Thread |
NSX News
|
0 | 87 | 0 | 15/03/18 | |
|
|||||||||
NSX News